The agc challenges six statements made in genzymes or sanofis sec filings that address fda approval of lemtrada. Registration document 2018 in french corporate social responsibility. The following is an excerpt from a 10k sec filing, filed by genzyme corp on 422001. Officers, directors and greater than 10 percent stockholders are required by sec regulations to furnish us with copies of all section 16a forms they file. Moreover, some of those representations and warranties may not be accurate or complete as of any specified date, may be subject to a contractual standard of materiality different from those generally applicable to genzymes sec filings or may have been used for purposes of allocating risk among genzyme, sanofiaventis and gc merger corp.
Notice of iranrelated disclosure filed pursuant to section r3 of the exchange act. Blood cancers and rare blood disorders account for some of the most challenging diseases. Fstar biotechnologische forschungsund entwicklungsges m. The consolidated financial statements of sanofi for the years ended december 31, 2016, 2015 and 2014 have been. Genzyme corp sec form 4 filings insider trading, stock buying and selling. Sec filings, wire and press releases, securities analysts reports, advisories, news articles and information readily. The companys product and service portfolio is focused on rare genetic disease disorders, renal diseases, orthopaedics, cancer, transplant. Plaintiffs filed suit under federal securities laws and state blue sky laws, alleging that sanofi made materially false or misleading statements regarding its breakthrough drug, lemtrada, designed to treat multiple sclerosis. A description of these risks and uncertainties can be found in pfizers most recent annual report on form 10k and in its subsequent reports on form 10q, including in the sections thereof captioned risk factors and forwardlooking information and factors that may affect future results, as well as in its subsequent reports on form.
Sanofi genzyme is an american biotechnology company based in cambridge, massachusetts. Access comprehensive sec filing information within seconds of the company filing to the sec. Patients and science are at the center of everything we do. Biomarin pharmaceutical and genzyme corporation restructure aldurazyme 5050 joint venture jan 4, 2008 10. Commission sec on march 11, 2016, to include information previously omitted from the original report in reliance on general instruction g to form 10k, which allows a registrant to incorporate by reference certain information from a definitive proxy statement filed with the sec within 120 days after the end of the fiscal year. Open quarterly report which provides a continuing view of a. Quarterly report which provides a continuing view of a companys financial position. The consolidated financial statements of sanofi for the years ended december 31. Isis partner, genzyme, is commercializing isis lead product, kynamro, in the united states for the treatment of patients with hofh. Annual report pursuant to section or 15d of the securities. The district court granted defendants motion to dismiss for failure to state a claim.
Under no circumstances does any information posted on represent a recommendation to purchase or sell a stock. Genzyme reports fourthquarter revenue business wire. Open quarterly report which provides a continuing view of a companys financial position in doc file. Genzyme said it received securities and exchange commission approval to proceed with a delayed plan to purchase biomatrix, a ridgefield, n. Tameko patterson, deputy director of new product launch, sanofi pasteur, shares the value of recognizing and celebrating black history not only during a single month but every day of the year. Sanofiaventis completes acquisition of genzyme corporation. Amgen takes no responsibility for, and exercises no control over, the organizations, views, or accuracy of the information contained on this server or site. Sanofi investor relations sanofi media relations sebastien martel jack cox tel. In re genzyme corporation shareholder litigation 10cv. Stock quote and company snapshot for denali therapeutics inc dnli, including profile, stock chart. Genzyme and veracyte announce global copromotion agreement to deliver personalized solution for thyroid patients cambridge, mass. Genzyme corporation genzyme is a biotechnology company.
Genzyme corporation industry is listed as diagnostic substances, nsk. In my previous job, i used file financial reports for many us companies. Isis patents provide strong and extensive protection for its drugs and technology. The start of fall can be a busy time, but making sure your family gets their annual flu vaccinations should be added to the top of your todo list. May 18, 2020 4 statement of changes in beneficial ownership.
Certification by the exchange approving securities for listing. Sanofi genzyme partners with patient organizations in. Sanofi genzyme begins pivotal phase 23 trial of olipudase. Genzymes lemtrada approved in mexico for treatment of. Genzyme therapeutics limited free company information from companies house including registered office address, filing history, accounts, annual return, officers, charges, business activity. Voyager therapeutics announces restructured gene therapy. Screenshots of actual 10k and 10q sec filings in pdf, word and excel formats. Sanofi has reached its limit for free report views. You may obtain information on the operation of the public reference room by calling the sec at 1800sec0330. Genz insider trading genzyme corp form 4 sec filings. The filing also incorporated four years of efficacy data from the cerdelga phase 2 study. During the class period, termeer was a signatory to genzymes form 10q and form 10k filings with the sec, was quoted in genzymes press releases, participated in conference calls with securities and market analysts, and made presentations at industry conferences on. Open quarterly report which provides a continuing view of a companys financial position in html.
About genzyme founded in 1981, genzyme has been present in france since 1994. Filing description, filing type, filing date, file downloads. In 2007, genzyme filed an ind for the use of hectorol in psoriasis patients. You may read or copy any materials we file with the sec at the secs public reference room at 100 f street, n. During 2015, there were no late form 3 or form 4 filings made by any of our directors and executive officers except for one form 4 filing by dr. The following is an excerpt from a 10k sec filing, filed by genzyme corp on 2292008. Groups ability to benefit from external growth opportunities as well as those discussed or identified in the public filings with the sec and the. Anita hochendoner, earl hochendoner, anita bova, joseph m carik, barbara j carik, amber britton, shawn britton, cheryl britton, thomas olszewski, darlene cookingham, david roberts, tom stanziano, heidi wittenberg, wendy stanziano, ricky ladd, kyle willink, michael masula, steve namnath, erin masula and stacy. Pdf sanofi does not currently have any hardcopy reports on.
Genzyme is also pursuing marketing approval of kynamro in other markets, including europe. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of justia. Genzyme remains committed to providing new hope for the ms community and plans this year. Sanofi does not currently have any hardcopy reports on. H, fstar biotechnology limited, sirion biotech gmbh, genzyme corporation, harvard university, the michael j.
Defendants filed with the sec, and disseminated to genzyme shareholders, a form 14d9 the 14d9 urging that. To view pages properly, enable javascript in your browser. The companys products and services are focused on rare inherited disorders, kidney disease, orthopaedics, cancer and transplant and autoimmune disease. Sanofiaventiss tender offer for genzyme papers in the ssrn. Food and drug administration fda has accepted for filing the new drug application nda for kynamro mipomersen sodium for the treatment of. Genzyme receives sec approval to proceed with biomatrix. Analyze up to 10 years of full 10k annual reports and quarterly 10q sec filings for genzyme corp genz using our online tools. Swch covering results of operations and financial condition. Genzyme benefits from the reach and resources of one of the worlds largest pharmaceutical companies, with a shared commitment to improving the lives of patients. Sanofi genzyme focuses on developing specialty treatments for debilitating diseases that are often difficult to diagnose and treat, providing hope to patients and their families.
Genzyme and alnylam expand collaboration on rare genetic. Genzyme corporation in college station tx company profile. Genzyme corporation sec 10k filings, 2008 and 2009. Each statement is to the effect that the company expects the fda to approve lemtrada prior to march 31, 2014, the cutoff date for the first cvr payment milestone. This includes every stage of biomedicine development, from the earliest stages of research to clinical trials and regulatory issues, through to manufacturing and sales. Since its acquisition in 2011, genzyme has been a fully owned subsidiary of sanofi. In 2010, genzyme was the worlds thirdlargest biotechnology company, employing more than 11,000 people around the world. The court agreed with the district courts reasoning and holding. Genzyme is an established leader in endocrinology globally. As far is know, sec requires the companies to file the reports in xbrl format and hence you may not find the filings in pdf format. Commercial credit report for genzyme corporation report. The genzyme board of directors met last night, unanimously affirmed its previous rejection of sanofis proposal, and instructed the company to send sanofi the following response letter.
108 176 189 584 936 237 160 657 1363 1077 381 1101 371 437 340 1085 977 920 912 1399 26 59 742 290 1463 238 804 872 635 446 1456 968 1346 783 536 1351